Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmadrug Inc
C.PHRX
Alternate Symbol(s):
LMLLF
Medical Care
Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural...
medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 31, 2022 8:39am
New Press Release - IIROC Trading Halt - PHRX
VANCOUVER, BC, May 31, 2022 /CNW/ - The following issues have been halted by IIROC:Company: Pharmadrug Inc.CSE Symbol: PHRXAll Issues: YesReason: At the request of the Company Pending NewsHalt Time (ET): 8:11 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 27, 2022 4:16pm
New Press Release - PharmaDrug Announces Closing of the First Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - May 27, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics...
read article.
(0)
•••
needhelp
X
View Profile
View Bullboard History
Comment by
needhelp
on May 25, 2022 3:12pm
RE:Filing for chapter 11
* no interest
(0)
•••
needhelp
X
View Profile
View Bullboard History
Post by
needhelp
on May 25, 2022 3:11pm
Filing for chapter 11
Looks like jo interest in this company. I wonder when cohen is going to file for bankruptcy?
(0)
•••
needhelp
X
View Profile
View Bullboard History
Post by
needhelp
on May 24, 2022 6:17pm
Pumping but going no where
All you pumpers and stupid WSR misinformation about clinical trials starting in months, where has it gotten you guys. Back to your 52 week low.
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Comment by
Blahblahblahbla
on May 18, 2022 8:10am
RE:When we going to get news about cep for covid?
Nice find looky. This stock requires a lot of time and patience. GLTA
(6)
•••
davwal
X
View Profile
View Bullboard History
Comment by
davwal
on May 17, 2022 2:29am
RE:When we going to get news about cep for covid?
thanks for the link
(1)
•••
Lookatmenow77
X
View Profile
View Bullboard History
Post by
Lookatmenow77
on May 16, 2022 3:48pm
When we going to get news about cep for covid?
https://news.cgtn.com/news/2022-05-13/China-grants-patent-to-new-COVID-19-medicine-1a0tTh07obe/index.html
(24)
•••
BMcCutcheon
X
View Profile
View Bullboard History
Post by
BMcCutcheon
on May 03, 2022 2:36pm
Pharmadrug advances opthalmology program
Pharmadrug advances opthalmology program
(20)
•••
Hammer1
X
View Profile
View Bullboard History
Post by
Hammer1
on May 03, 2022 8:19am
News
https://stockhouse.com/news/press-releases/2022/05/03/pharmadrug-advances-opthalmology-program-with-final-selection-of-lead-dmt
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Post by
Blahblahblahbla
on Apr 11, 2022 6:39pm
Looks like more news coming soon
PharmaDrug advances DMT-analogue glaucoma program with fabrication of medical device PharmaDrug Inc CEO Daniel Cohen tells Proactive it has successfully completed the fabrication of
...more
(17)
•••
SuperTrader1
X
View Profile
View Bullboard History
Comment by
SuperTrader1
on Apr 10, 2022 5:00pm
RE:RE:PharmaDrug Advances DMT-Analogue Program for Glaucoma
American Investors are now moving in, see movement in next week. $THRX will be a Wimmer!
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Comment by
Blahblahblahbla
on Apr 09, 2022 4:36pm
RE:PharmaDrug Advances DMT-Analogue Program for Glaucoma
Exciting times for shareholders. Everything moving forward and into place nicely.
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Apr 07, 2022 8:29am
PharmaDrug Advances DMT-Analogue Program for Glaucoma
PharmaDrug Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure 2022-04-07 07:31 ET -
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed
EnviroGold Global Announces Appointment of Chief Operating Officer